{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T03:01:30Z","timestamp":1770433290174,"version":"3.49.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"vor","delay-in-days":29,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000864","name":"Michael J. Fox Foundation","doi-asserted-by":"crossref","award":["MJFF-022801"],"award-info":[{"award-number":["MJFF-022801"]}],"id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000864","name":"Michael J. Fox Foundation","doi-asserted-by":"crossref","award":["MJFF-022801"],"award-info":[{"award-number":["MJFF-022801"]}],"id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000864","name":"Michael J. Fox Foundation","doi-asserted-by":"crossref","award":["MJFF-022801"],"award-info":[{"award-number":["MJFF-022801"]}],"id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000864","name":"Michael J. Fox Foundation","doi-asserted-by":"crossref","award":["MJFF-022801"],"award-info":[{"award-number":["MJFF-022801"]}],"id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000864","name":"Michael J. Fox Foundation","doi-asserted-by":"crossref","award":["MJFF-022801"],"award-info":[{"award-number":["MJFF-022801"]}],"id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000864","name":"Michael J. Fox Foundation","doi-asserted-by":"crossref","award":["MJFF-022801"],"award-info":[{"award-number":["MJFF-022801"]}],"id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000864","name":"Michael J. Fox Foundation","doi-asserted-by":"crossref","award":["MJFF-022801"],"award-info":[{"award-number":["MJFF-022801"]}],"id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000864","name":"Michael J. Fox Foundation","doi-asserted-by":"crossref","award":["MJFF-022801"],"award-info":[{"award-number":["MJFF-022801"]}],"id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Parkinsons Dis."],"DOI":"10.1038\/s41531-025-01248-w","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T12:59:46Z","timestamp":1767790786000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prediction of impulse control disorders in Parkinson\u2019s disease through a longitudinal machine learning study"],"prefix":"10.1038","volume":"12","author":[{"given":"Alexandros","family":"Vamvakas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim","family":"Van Balkom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guido","family":"Van Wingen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Booij","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Weintraub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henk W.","family":"Berendse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Odile A.","family":"van den Heuvel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris","family":"Vriend","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,7]]},"reference":[{"key":"1248_CR1","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s00441-017-2771-0","volume":"373","author":"C Vriend","year":"2018","unstructured":"Vriend, C. The neurobiology of impulse control disorders in Parkinson\u2019s disease: from neurotransmitters to neural networks. Cell Tissue Res. 373, 327\u2013336 (2018).","journal-title":"Cell Tissue Res."},{"key":"1248_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.1023574","volume":"14","author":"J Dulski","year":"2022","unstructured":"Dulski, J., Uitti, R. J., Ross, O. A. & Wszolek, Z. K. Genetic architecture of Parkinson\u2019s disease subtypes - Review of the literature. Front Aging Neurosci. 14, 1023574 (2022).","journal-title":"Front Aging Neurosci."},{"key":"1248_CR3","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1136\/jnnp-2015-312848","volume":"87","author":"J Kraemmer","year":"2016","unstructured":"Kraemmer, J. et al. Clinical-genetic model predicts incident impulse control disorders in Parkinson\u2019s disease. J. Neurol. Neurosurg. Psychiatry 87, 1106\u20131111 (2016).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"1248_CR4","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1002\/acn3.51569","volume":"9","author":"D Weintraub","year":"2022","unstructured":"Weintraub, D. et al. Genetic prediction of impulse control disorders in Parkinson\u2019s disease. Ann. Clin. Transl. Neurol. 9, 936\u2013949 (2022).","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"1248_CR5","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1109\/OJEMB.2022.3178295","volume":"3","author":"J Faouzi","year":"2022","unstructured":"Faouzi, J. et al. Machine Learning-Based Prediction of Impulse Control Disorders in Parkinson\u2019s Disease From Clinical and Genetic Data. IEEE Open J. Eng. Med Biol. 3, 96\u2013107 (2022).","journal-title":"IEEE Open J. Eng. Med Biol."},{"key":"1248_CR6","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1093\/ijnp\/pyaa028","volume":"23","author":"S Reden\u0161ek","year":"2020","unstructured":"Reden\u0161ek, S., Jenko Bizjan, B., Tro\u0161t, M. & Dol\u017ean, V. Clinical and Clinical-Pharmacogenetic Models for Prediction of the Most Common Psychiatric Complications Due to Dopaminergic Treatment in Parkinson\u2019s Disease. Int J. Neuropsychopharmacol. 23, 496\u2013504 (2020).","journal-title":"Int J. Neuropsychopharmacol."},{"key":"1248_CR7","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3389\/fneur.2018.00109","volume":"9","author":"AH Erga","year":"2018","unstructured":"Erga, A. H. et al. Dopaminergic and Opioid Pathways Associated with Impulse Control Disorders in Parkinson\u2019s Disease. Front. Neurol. 9, 109 (2018).","journal-title":"Front. Neurol."},{"key":"1248_CR8","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1007\/s00259-019-04396-3","volume":"46","author":"I Navalpotro-Gomez","year":"2019","unstructured":"Navalpotro-Gomez, I. et al. Nigrostriatal dopamine transporter availability, and its metabolic and clinical correlates in Parkinson\u2019s disease patients with impulse control disorders. Eur. J. Nucl. Med Mol. Imaging 46, 2065\u20132076 (2019).","journal-title":"Eur. J. Nucl. Med Mol. Imaging"},{"key":"1248_CR9","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.3389\/fneur.2018.01018","volume":"9","author":"A Martini","year":"2018","unstructured":"Martini, A. et al. Dopaminergic Neurotransmission in Patients With Parkinson\u2019s Disease and Impulse Control Disorders: A Systematic Review and Meta-Analysis of PET and SPECT Studies. Front. Neurol. 9, 1018 (2018).","journal-title":"Front. Neurol."},{"key":"1248_CR10","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1136\/jnnp-2015-311827","volume":"87","author":"KM Smith","year":"2016","unstructured":"Smith, K. M., Xie, S. X. & Weintraub, D. Incident impulse control disorder symptoms and dopamine transporter imaging in Parkinson disease. J. Neurol. Neurosurg. Psychiatry 87, 864\u2013870 (2016).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"1248_CR11","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1002\/mds.25886","volume":"29","author":"C Vriend","year":"2014","unstructured":"Vriend, C. et al. Reduced dopamine transporter binding predates impulse control disorders in Parkinson\u2019s disease. Mov. Disord. 29, 904\u2013911 (2014).","journal-title":"Mov. Disord."},{"key":"1248_CR12","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.nicl.2017.08.021","volume":"16","author":"A Rahmim","year":"2017","unstructured":"Rahmim, A. et al. Improved prediction of outcome in Parkinson\u2019s disease using radiomics analysis of longitudinal DAT SPECT images. Neuroimage Clin. 16, 539\u2013544 (2017).","journal-title":"Neuroimage Clin."},{"key":"1248_CR13","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.3390\/diagnostics13101691","volume":"13","author":"M Hosseinzadeh","year":"2023","unstructured":"Hosseinzadeh, M. et al. Prediction of cognitive decline in parkinson's disease using clinical and DAT SPECT imaging features, and hybrid machine learning systems. Diagnostics (Basel) 13, 1691 (2023).","journal-title":"Diagnostics (Basel)"},{"key":"1248_CR14","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.nicl.2016.02.012","volume":"12","author":"A Rahmim","year":"2016","unstructured":"Rahmim, A. et al. Application of texture analysis to DAT SPECT imaging: Relationship to clinical assessments. Neuroimage Clin. 12, e1\u2013e9 (2016).","journal-title":"Neuroimage Clin."},{"key":"1248_CR15","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/bs.irn.2017.04.006","volume":"133","author":"D Weintraub","year":"2017","unstructured":"Weintraub, D. & Claassen, D. O. Impulse Control and Related Disorders in Parkinson\u2019s Disease. Int Rev. Neurobiol. 133, 679\u2013717 (2017).","journal-title":"Int Rev. Neurobiol."},{"key":"1248_CR16","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1111\/ene.14590","volume":"28","author":"S Jes\u00fas","year":"2021","unstructured":"Jes\u00fas, S. et al. Integrating genetic and clinical data to predict impulse control disorders in Parkinson\u2019s disease. Eur. J. Neurol. 28, 459\u2013468 (2021).","journal-title":"Eur. J. Neurol."},{"key":"1248_CR17","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.parkreldis.2020.03.017","volume":"75","author":"J Ihle","year":"2020","unstructured":"Ihle, J. et al. Parkinson\u2019s disease polygenic risk score is not associated with impulse control disorders: A longitudinal study. Parkinsonism Relat. Disord. 75, 30\u201333 (2020).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1248_CR18","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.parkreldis.2021.04.003","volume":"86","author":"J Faouzi","year":"2021","unstructured":"Faouzi, J., Couvy-Duchesne, B., Bekadar, S., Colliot, O. & Corvol, J. C. Exploratory analysis of the genetics of impulse control disorders in Parkinson\u2019s disease using genetic risk scores. Parkinsonism Relat. Disord. 86, 74\u201377 (2021).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1248_CR19","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1136\/jnnp-2017-317007","volume":"89","author":"L Ricciardi","year":"2018","unstructured":"Ricciardi, L., Lambert, C., De Micco, R., Morgante, F. & Edwards, M. Can we predict development of impulsive-compulsive behaviours in Parkinson\u2019s disease? J. Neurol. Neurosurg. Psychiatry 89, 476\u2013481 (2018).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"1248_CR20","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1002\/mdc3.13117","volume":"8","author":"JT Hinkle","year":"2021","unstructured":"Hinkle, J. T., Perepezko, K., Gonzalez, L. L., Mills, K. A. & Pontone, G. M. Apathy and Anxiety in De Novo Parkinson\u2019s Disease Predict the Severity of Motor Complications. Mov. Disord. Clin. Pract. 8, 76\u201384 (2021).","journal-title":"Mov. Disord. Clin. Pract."},{"key":"1248_CR21","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1111\/cns.14173","volume":"29","author":"D Meng","year":"2023","unstructured":"Meng, D., Jin, Z., Wang, Y. & Fang, B. Longitudinal cognitive changes in patients with early Parkinson\u2019s disease and neuropsychiatric symptoms. CNS Neurosci. Ther. 29, 2259\u20132266 (2023).","journal-title":"CNS Neurosci. Ther."},{"key":"1248_CR22","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-019-0980-5","volume":"19","author":"AA Roussakis","year":"2019","unstructured":"Roussakis, A. A., Lao-Kaim, N. P. & Piccini, P. Brain Imaging and Impulse Control Disorders in Parkinson\u2019s Disease. Curr. Neurol. Neurosci. Rep. 19, 67 (2019).","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"1248_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-37054-8","volume":"13","author":"G Hernadi","year":"2023","unstructured":"Hernadi, G. et al. White matter hyperintensities associated with impulse control disorders in Parkinson\u2019s Disease. Sci. Rep. 13, 10594 (2023).","journal-title":"Sci. Rep."},{"key":"1248_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2024.1364402","volume":"16","author":"C Gan","year":"2024","unstructured":"Gan, C. et al. Aberrant brain topological organization and granger causality connectivity in Parkinson\u2019s disease with impulse control disorders. Front Aging Neurosci. 16, 1364402 (2024).","journal-title":"Front Aging Neurosci."},{"key":"1248_CR25","doi-asserted-by":"publisher","first-page":"e078378","DOI":"10.1136\/bmj-2023-078378","volume":"385","author":"GS Collins","year":"2024","unstructured":"Collins, G. S. et al. TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods. BMJ 385, e078378 (2024).","journal-title":"BMJ"},{"key":"1248_CR26","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.pneurobio.2011.09.005","volume":"95","author":"PPM Initiative","year":"2011","unstructured":"Initiative, P. P. M. The Parkinson Progression Marker Initiative (PPMI). Prog. Neurobiol. 95, 629\u2013635 (2011).","journal-title":"Prog. Neurobiol."},{"key":"1248_CR27","doi-asserted-by":"publisher","first-page":"3703","DOI":"10.1002\/hbm.22873","volume":"36","author":"JP Trujillo","year":"2015","unstructured":"Trujillo, J. P. et al. Impaired planning in Parkinson\u2019s disease is reflected by reduced brain activation and connectivity. Hum. Brain Mapp. 36, 3703\u20133715 (2015).","journal-title":"Hum. Brain Mapp."},{"key":"1248_CR28","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1002\/mds.22571","volume":"24","author":"D Weintraub","year":"2009","unstructured":"Weintraub, D. et al. Validation of the questionnaire for impulsive-compulsive disorders in Parkinson\u2019s disease. Mov. Disord. 24, 1461\u20131467 (2009).","journal-title":"Mov. Disord."},{"key":"1248_CR29","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1002\/mds.24023","volume":"27","author":"D Weintraub","year":"2012","unstructured":"Weintraub, D. et al. Questionnaire for Impulsive-Compulsive Disorders in Parkinson\u2019s Disease-Rating Scale. Mov. Disord. 27, 242\u2013247 (2012).","journal-title":"Mov. Disord."},{"key":"1248_CR30","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1002\/mds.27689","volume":"34","author":"AH Evans","year":"2019","unstructured":"Evans, A. H. et al. Scales to assess impulsive and compulsive behaviors in Parkinson\u2019s disease: Critique and recommendations. Mov. Disord. 34, 791\u2013798 (2019).","journal-title":"Mov. Disord."},{"key":"1248_CR31","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1002\/mds.29410","volume":"38","author":"ST Jost","year":"2023","unstructured":"Jost, S. T. et al. Levodopa Dose Equivalency in Parkinson\u2019s Disease: Updated Systematic Review and Proposals. Mov. Disord. 38, 1236\u20131252 (2023).","journal-title":"Mov. Disord."},{"key":"1248_CR32","first-page":"350","volume":"32","author":"FJ Garc\u00eda-G\u00f3mez","year":"2013","unstructured":"Garc\u00eda-G\u00f3mez, F. J. et al. [Elaboration of the SPM template for the standardization of SPECT images with 123I-Ioflupane]. Rev. Esp. Med Nucl. Imagen Mol. 32, 350\u2013356 (2013).","journal-title":"Rev. Esp. Med Nucl. Imagen Mol."},{"key":"1248_CR33","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.neuroimage.2012.10.005","volume":"65","author":"D Salas-Gonzalez","year":"2013","unstructured":"Salas-Gonzalez, D., G\u00f3rriz, J. M., Ram\u00edrez, J., Ill\u00e1n, I. A. & Lang, E. W. Linear intensity normalization of FP-CIT SPECT brain images using the \u03b1-stable distribution. Neuroimage 65, 449\u2013455 (2013).","journal-title":"Neuroimage"},{"key":"1248_CR34","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.neuroimage.2010.06.044","volume":"54","author":"AC Tziortzi","year":"2011","unstructured":"Tziortzi, A. C. et al. Imaging dopamine receptors in humans with [11C]-(+)-PHNO: dissection of D3 signal and anatomy. Neuroimage 54, 264\u2013277 (2011).","journal-title":"Neuroimage"},{"key":"1248_CR35","doi-asserted-by":"publisher","first-page":"e104","DOI":"10.1158\/0008-5472.CAN-17-0339","volume":"77","author":"JJM van Griethuysen","year":"2017","unstructured":"van Griethuysen, J. J. M. et al. Computational Radiomics System to Decode the Radiographic Phenotype. Cancer Res. 77, e104\u2013e107 (2017).","journal-title":"Cancer Res."},{"key":"1248_CR36","unstructured":"R Core Team. R: A language and environment for statistical computing: R Foundation for Statistical Computing, Vienna, Austria; 2021 [Available from: https:\/\/www.R-project.org\/."},{"key":"1248_CR37","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc.: Ser. B (Methodol.). 57, 289\u2013300 (1995).","journal-title":"J. R. Stat. Soc.: Ser. B (Methodol.)."},{"key":"1248_CR38","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1023\/A:1024068626366","volume":"52","author":"C Nadeau","year":"2003","unstructured":"Nadeau, C. & Bengio, Y. Inference for the generalization error. Mach. Learn. 52, 239\u2013281 (2003).","journal-title":"Mach. Learn."},{"key":"1248_CR39","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-3-540-24775-3_3","volume":"3056","author":"R Bouckaert","year":"2004","unstructured":"Bouckaert, R., Frank, E., Dai, H., Srikant, R. & Zhang, C. Evaluating the replicability of significance tests for comparing learning algorithms. Adv. Knowl. Discov. Data Min., Proc. 3056, 3\u201312 (2004).","journal-title":"Adv. Knowl. Discov. Data Min., Proc."},{"key":"1248_CR40","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.1002\/mds.28706","volume":"36","author":"MA Laansma","year":"2021","unstructured":"Laansma, M. A. et al. International Multicenter Analysis of Brain Structure Across Clinical Stages of Parkinson\u2019s Disease. Mov. Disord. 36, 2583\u20132594 (2021).","journal-title":"Mov. Disord."},{"key":"1248_CR41","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1002\/mds.26435","volume":"30","author":"JG Hentz","year":"2015","unstructured":"Hentz, J. G. et al. Simplified conversion method for unified Parkinson\u2019s disease rating scale motor examinations. Mov. Disord. 30, 1967\u20131970 (2015).","journal-title":"Mov. Disord."},{"key":"1248_CR42","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1001\/archpsyc.1961.01710120031004","volume":"4","author":"AT Beck","year":"1961","unstructured":"Beck, A. T., Ward, C. H., Mendelson, M., Mock, J. & Erbaugh, J. An inventory for measuring depression. Arch. Gen. psychiatry 4, 561\u2013571 (1961).","journal-title":"Arch. Gen. psychiatry"},{"key":"1248_CR43","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1300\/J018v05n01_09","volume":"5","author":"JA Yesavage","year":"1986","unstructured":"Yesavage, J. A. & Sheikh, J. I. 9\/Geriatric depression scale (GDS) recent evidence and development of a shorter version. Clin. gerontologist. 5, 165\u2013173 (1986).","journal-title":"Clin. gerontologist."},{"key":"1248_CR44","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/B978-0-444-52002-9.00013-9","volume":"106","author":"D Maust","year":"2012","unstructured":"Maust, D. et al. Psychiatric rating scales. Handb. Clin. Neurol. 106, 227\u2013237 (2012).","journal-title":"Handb. Clin. Neurol."},{"key":"1248_CR45","unstructured":"Spielberger, C. D., Goruch, R., Lushene, R., Vagg, P. & Jacobs, G. Manual for the state-trait inventory STAI (form Y). Mind Garden, Palo Alto, CA, USA. (1983)."},{"key":"1248_CR46","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1002\/mds.26062","volume":"29","author":"I van Steenoven","year":"2014","unstructured":"van Steenoven, I. et al. Conversion between mini-mental state examination, montreal cognitive assessment, and dementia rating scale-2 scores in Parkinson\u2019s disease. Mov. Disord. 29, 1809\u20131815 (2014).","journal-title":"Mov. Disord."}],"container-title":["npj Parkinson's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01248-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01248-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01248-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T14:04:39Z","timestamp":1770300279000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01248-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,7]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1248"],"URL":"https:\/\/doi.org\/10.1038\/s41531-025-01248-w","relation":{},"ISSN":["2373-8057"],"issn-type":[{"value":"2373-8057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,7]]},"assertion":[{"value":"30 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.B. is a consultant at GE Healthcare (all related payments to the institute). D.W. receives research funding and salary support from the Michael J. Fox Foundation for serving on the Executive Steering Committee of the Parkinson\u2019s Progression Markers Initiative study. The authors declare no other financial or non-financial competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"38"}}